The tender offer described herein has not yet commenced, and this material is neither an offer to purchase nor a solicitation of an offer to sell shares of Lincare Holdings Inc. The acquisition loan will be refinanced by debt and equity issuances. The funding of the transaction will be done by an acquisition loan in the total amount of USD 4.5 bn and through available cash. Completion of the offer and merger is subject to receipt of regulatory approvals and other customary closing conditions. Closing is expected for the third quarter of fiscal year 2012. The planned acquisition has a total transaction volume of approximately USD 4.6 billion. shareholders of USD 41.50 per common share, followed by a merger. by submitting a cash offer to the Lincare Holdings Inc. Linde intends to acquire all outstanding shares of Lincare Holdings Inc. Munich, 1 July 2012 - Linde has signed a merger agreement with Lincare Holdings Inc., a US-based homecare health company. Regulators, flowmeters and oxygen conserving devices The Group is committed to technologies and products that unite the goals of customer value and sustainable development.įor more information, see The Linde Group online at. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment – in every one of its business areas, regions and locations across the globe. The strategy of the Group is geared towards long-term profitable growth and focuses on the expansion of its international business with forward-looking products and services. In the 2011 financial year, Linde generated revenue of EUR 13.787 bn. The Linde Group is a world-leading gases and engineering company with around 62,000 employees in more than 100 countries worldwide. Linde's pro-forma annual revenue in the healthcare product area is now around EUR 3 bn, which makes it the largest supplier of medical gases and related services in the world. In April, the Group acquired Air Products' Continental European homecare business and in August it concluded its purchase of the US homecare company Lincare Inc. In France, Linde’s portfolio also includes Infusion, Nutrition and Insulin Therapy.Ĭalea is Linde's third acquisition in 2012 in the promising healthcare business. It comprises respiratory services such as oxygen therapy, sleep therapy and ventilation services. Homecare is the term applied to medical services relating to the treatment of patients in settings other than hospitals. The acquisition will significantly improve Linde’s position on the French homecare market. The transaction is expected to be completed at the beginning of 2013.Ĭalea will complement the European homecare operations acquired by Linde from Air Products in spring. Calea generated revenue in the 2011 financial year of EUR 28 m with around 200 employees. Munich, 17 December 2012 – The technology company The Linde Group has signed an agreement to acquire the homecare company Calea France SAS (Sèvres, France).
Will complement Linde's existing operations in the European homecare market Quality, Health, Safety & Environment (QHSE)Ĭracking furnaces for ethylene productionįired heaters and waste heat recovery unitsĬryogenic tanks and air-heated vaporizersĬoldboxes, packaged units and cryogenic columns Linde Engineering South Africa (Pty) Ltd. Hydro-Chem, a division of Linde Engineering North America.
0 kommentar(er)
